|

Lutetium Lu 177-Edotreotide Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 177Lu-edotreotide

Pipeline

Phase 1: 1

Top Sponsors

  • ITM Solucin GmbH1

Indications

  • Peripheral Primitive Neuroectodermal Tumor1
  • CNS Tumors1
  • NETs1
  • Somatostatin Receptor Positive1
  • GIST1

Philadelphia, Pennsylvania1 trial

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

The Children's Hospital of Philadelphia (CHOP)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.